Patients with type 2 diabetes should be treated to achieve an A1C between 7 percent and 8 percent rather than 6.5 percent to 7 percent, the American College of Physicians (ACP) recommends in an evidence-based guidance statement ...
Mar 5, 2018
0
8
(HealthDay)—In patients with type 2 diabetes, more aggressive glucose-control strategies have variable short-term effects on microvascular complications, but they do not reduce the rate of myocardial infarction over four ...
Aug 1, 2013
0
0
(HealthDay)—Compared with routine care, early multifactorial therapy did not result in superior microvascular outcomes at five years in individuals with screening-detected diabetes, according to research published online ...
May 20, 2014
0
0
(HealthDay)—Microvascular complications and poor glycemic control are associated with the severity of periodontitis, according to a study published online Jan. 27 in the Journal of Diabetes Investigation.
Feb 6, 2017
0
0
(HealthDay)—For adults with type 1 diabetes, glycemic control may be worse than previously thought, and rates of all complications increase with increasing hemoglobin A1c (HbA1c), according to a study published online Sept. ...
Oct 1, 2019
0
1
(HealthDay)—Measures of glycemic variability in type 1 diabetes, based on complete quarterly 7-point glucose profiles, fail to provide evidence that glycemic variability contributes to the risk of development or progression ...
Apr 18, 2017
0
0
Preliminary results from the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) do not support administration of aliskiren on top of standard therapy with renin-angiotensin-aldosterone system (RAAS) ...
Aug 27, 2012
0
0
"People are living longer with type 1 diabetes, and the onset of complications is taking longer," says Hillary Keenan, Ph.D., a Joslin Diabetes Center Assistant Investigator and co-Principal Investigator on the Joslin 50-Year ...
Jul 27, 2017
0
1
Treatments used to decrease the development of type 2 diabetes continue to be effective an average of 15 years later, according to the latest findings of the Diabetes Prevention Program Outcomes Study, a landmark study funded ...
Jun 16, 2014
0
0
The development of common diabetes complications that can lead to blindness and amputations could be reduced by taking statins, indicates new research published in The Lancet Diabetes & Endocrinology.
Sep 10, 2014
0
0
